image
Revolution Medicines, Inc. RVMD
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 55.13
-3.9 %
$ 9.27 B
Market Cap
-15.06
P/E
CASH FLOW STATEMENT
-351 M OPERATING CASH FLOW
-56.23%
Growth Rates
1Year -56.23%
3Years -51.88%
5Years -210.80%
7Years 0.00%
10Years 0.00%
-343 M INVESTING CASH FLOW
-1320.63%
Growth Rates
1Year -1320.63%
3Years -13.51%
5Years -203.11%
7Years 0.00%
10Years 0.00%
1.23 B FINANCING CASH FLOW
307.79%
Growth Rates
1Year 307.79%
3Years 42.73%
5Years 82.42%
7Years 0.00%
10Years 0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Revolution Medicines, Inc.
image
Net Income -436 M
Depreciation & Amortization 9.31 M
Capital Expenditures -7.73 M
Stock-Based Compensation 61.8 M
Change in Working Capital 36.8 M
Others -17.3 M
Free Cash Flow -358 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
OPERATING CASH FLOW
Net Income (436.4) (248.7) (187.1) (108.2) (47.7) (41.8) (31.1)
Depreciation & Amortization 9.3 9.7 7.3 6.5 3.3 1.8 1.2
Deferred Income Tax (3.9) (0.4) 0 (0.4) (4.4) 0.2 0
Stock Based Compensation 61.8 31.2 20.7 8.9 3.2 0.9 0.1
Other Operating Activities (18.1) (2.6) 3.1 1.3 4.7 2.1 0.5
Change in Working Capital 36.8 (13.5) 8.7 (8.3) (8.8) 38.1 4.7
Cash From Operations (350.6) (224.4) (147.2) (100.1) (49.6) 1.2 (25.1)
INVESTING CASH FLOW
Capital Expenditures (7.7) (10.8) (6.5) (2.9) (2.6) (1.5) (1.6)
Other Items (334.9) (13.3) (135.6) (231.3) (99.4) 0.2 0
Cash From Investing Activities (342.6) (24.1) (142.1) (234.2) (102.0) (1.3) (1.6)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 45 K (0.1) 0
Total Debt Repaid 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0
Other Financing Activities 843.4 3.4 2.9 2.7 98.7 60.8 45.2
Cash From Financing Activities 1 229.2 301.4 294.2 422.8 98.7 60.8 22.7
CHANGE IN CASH
Net Change In Cash 536.0 52.9 4.9 88.5 (52.9) 60.7 (4.1)
FREE CASH FLOW
Free Cash Flow (358.3) (235.2) (153.7) (103.0) (52.2) (0.3) (26.7)